An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
|Articles|November 18, 2005
Avian Flu and the Global Threat of Emerging Respiratory Diseases
Advertisement
How serious is the threat posed by bird flu to human health? How might the virus change to spread more easily between humans? Are influenza epidemics cyclical, and can one predict when the next one will strike? What related diseases do we need to be on the look out for? And what measures are being taken to develop effective vaccines and drugs?
In a free public lecture on Saturday, Dec. 3, 2005 at 5:30 p.m. in Cold Spring Harbor Laboratorys Grace Auditorium, Dr. Kanta Subbarao will address these and many other intriguing questions about the H5N1 influenza strain of avian influenza, commonly known as bird flu.
Subbarao is currently a senior investigator in the Laboratory of Infectious Diseases at National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health. The laboratorys research is focused on the development of vaccines against pandemic strains of influenza and the development of animal models and the evaluation of vaccines against the severe acute respiratory syndrome (SARS) coronavirus. Her influenza research aims to identify and prioritize potential pandemic strains of influenza to target for vaccine development, with a particular focus on emerging strains such as the H5N1 strain of avian influenza.
Subbarao received her MB, BS, in 1982 from the University of Madras, India, and completed a residency in pediatrics at Cardinal Glennon Memorial Hospital for Children at Saint Louis University. She completed a fellowship in pediatric infectious diseases and earned an MPH in epidemiology from the University of Oklahoma Health Sciences Center. After postdoctoral training in the Laboratory of Infectious Diseases (LID), NIAID, she was on faculty at McGill University, Montreal, Canada, and subsequently served as Chief of the Molecular Genetics Section of the Influenza Branch at the Centers for Disease Control and Prevention in Atlanta. Subbarao joined the Laboratory of Infectious Diseases as a Senior Investigator in 2002.
The lecture will last 35 to 40 minutes, followed by a question-and-answer session. Cold Spring Harbor Laboratory is located at 1 Bungtown Road in Cold Spring Harbor, N.Y. For more information, call (516) 367-8800.
Advertisement
Related to this article
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
UPMC’s genomic surveillance initiative earned national recognition for patient safety. Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, explains how the award could help infection preventionists secure leadership support and sustainable funding for earlier outbreak detection.
Knowing the protocol is only the beginning. In The Clean Bite, Sherrie Busby explores how explaining the why, addressing staff concerns, and creating clear procedures can help dental teams make infection control part of everyday practice.
What might infection prevention rounds miss when visible conditions dominate the conversation? Tommy Davis, PhD, CMIP, a member of ICT's executive advisory board, makes the case for structured observations of clinical workflows, shared accountability, and greater attention to environmental services staff’s insights.
A proposed $27.7 million reduction in AHRQ funding raises questions about support for infection prevention research and implementation. Here is what the September 25 announcement identifies, as well as what remains unknown about specific IPC programs.
Advertisement
Advertisement